| ENLIVEX THERAPEUTICS |
| Israel |
| Gesundheit |
| IL0011319527 / A119KH |
| 1BT (Frankfurt) / ENLV (NASDAQ) |
| FRA:1BT, ETR:1BT, 1BT:GR, NASDAQ:ENLV |
| - |
| https://www.enlivex.com/ |
|
Enlivex Therapeutics Ltd. is a biopharmaceutical c..
>Volltext.. |
| 18.91 Mio. EUR |
| 3.88 Mio. EUR |
| - |
| -12.44 Mio. EUR |
| -11.03 Mio. EUR |
| -0.46 EUR |
| 0.61 Mio. EUR |
| 3.64 Mio. EUR |
| -10.65 Mio. EUR |
| 6.04 |
| - |
| 36.35% |
| - |
| - |
| - |
| - |
| ENLIVEX |
| 24.11.25 |
|
||||
|
||||
|